Skip to content
2000
Volume 8, Issue 5
  • ISSN: 1570-1786
  • E-ISSN: 1875-6255

Abstract

The spirostanic side chain of pennogenin can be quantitatively transformed under mild acidic conditions in a 22-oxocholestanic framework through a one step procedure. This methodology is the shortest way to afford the 3,16,26- trihydroxy-22-oxocholestanic derivative, analogue of the protected aglycon of the potent antitumor agent OSW-1. The primary hydroxyl group at C-26 could be selectively transformed.

Loading

Article metrics loading...

/content/journals/loc/10.2174/157017811795685018
2011-06-01
2025-09-15
Loading full text...

Full text loading...

/content/journals/loc/10.2174/157017811795685018
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test